Anti-Covid drug molnupiravir may have led to virus mutations, study says

Pharmaceutical giant Merck’s antiviral pill molnupiravir was one of the earliest treatments rolled out during the pandemic to prevent Covid becoming more severe in vulnerable people.

Read the original article at South China Morning Post